insulin glargine-aldy
insulin glargine-aldy is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including LANGLARA. Available dosage form: injection, solution.
Drug Details
- Generic Name
- insulin glargine-aldy
- Brand Names
- LANGLARA
- Application Number
- BLA761412
- Sponsor
- Lanexa Biologics, LLC
- NDC Codes
- 1
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- INSULIN GLARGINE
Indications and Usage
1 INDICATIONS AND USAGE LANGLARA is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. LANGLARA is a long-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 ) Limitations of Use Not recommended for the treatment of diabetic ketoacidosis. ( 1 ) Limitations of Use LANGLARA is not recommended for the treatment of diabetic ketoacidosis.